GSK PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 26.0%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 26.0%
Tue, 5 Feb

GSK PHARMA has announced its results for the quarter ended December 2018. Here is a detailed performance review of the same:

GSK PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Dec-17*
3
Sep-18*
3
Dec-18*
QoQ ChangeYoY Change
Net SalesRs m7,0398,1638,2541.1%17.3%
Other incomeRs m12014816410.8%37.4%
TurnoverRs m7,1598,3118,4181.3%17.6%
ExpensesRs m5,6216,5126,8805.7%22.4%
Gross profitRs m1,4181,5341,6557.9%16.7%
DepreciationRs m1341151204.7%-10.0%
InterestRs m021-77.3%0.0%
Profit before taxRs m1,4041,5651,6988.5%20.9%
TaxRs m5075575682.0%12.1%
Profit after taxRs m8971,0081,13012.1%26.0%
Gross profit margin%20.118.820.0
Effective tax rate%36.135.633.5
Net profit margin%12.512.113.4
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 17.3% on a year-on-year (YoY) basis. The expenses were up by 22.4% YoY during the same period.
  • The company's operating profit increased by 16.7% YoY during the quarter. Consequently, operating profit margins remained same and stood at 20.0% in 3QFY19.
  • Depreciation charges declined by 10.0% and finance costs increased by 0.0% YoY, respectively.
  • Other income increased by 37.4% YoY during the quarter.
  • Net profit for the quarter increased by 26.0% YoY. Net profit margins during the quarter increased from 12.5% in 3QFY18 to 13.4% in 3QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 1.1% on a quarter-on-quarter (QoQ) basis. The expenses were up by 5.7% QoQ during the same period.
  • The company's operating profit increased by 7.9% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 20.0% in 3QFY19 as against 18.8% in 2QFY18.
  • Net profit for the quarter increased by 12.1% QoQ, while net profit margins increased from 12.1% in 2QFY18 to 13.4% in 3QFY19.

To see how GSK PHARMA has performed over the last eight quarters, please visit here.

GSK PHARMA Share Price Performance

Over the last one year, GSK PHARMA share price has moved up from Rs 1,230.6 to Rs 1,401.3, registering a Gain of Rs 170.7 or around 13.9%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,893.6 (up 0.6%). Over the last one year it has moved down from 14,075.0 to 13,893.6, a gain of 181 points (down 1.3%).

Overall, the S&P BSE SENSEX is up 5.2% over the year.

Current Valuations

At the current price of Rs 1,401.3, the price to earnings (P/E) ratio of GSK PHARMA stands at 58.2 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 11.5 times.

Equitymaster requests your view! Post a comment on "GSK PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 26.0%". Click here!

  

Related Views on News

GSK PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 398.9% (Quarterly Result Update)

Oct 25, 2019 | Updated on Oct 25, 2019

For the quarter ended September 2019, GSK PHARMA has posted a net profit of Rs 5 bn (up 398.9% YoY). Sales on the other hand came in at Rs 9 bn (up 8.1% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 28.1% (Quarterly Result Update)

Jul 24, 2019 | Updated on Jul 24, 2019

For the quarter ended June 2019, GSK PHARMA has posted a net profit of Rs 1 bn (up 28.1% YoY). Sales on the other hand came in at Rs 8 bn (up 7.1% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of GSK PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of GSK PHARMA. Also includes updates on the valuation of GSK PHARMA.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

The Smartest Stock to Buy for 2020(Profit Hunter)

Nov 14, 2019

Small-cap stocks are selling at bargain prices today and are poised to generate a lot of wealth in 2020 and beyond...

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

The One Trade I'm Most Bullish on Now

Nov 12, 2019

A highly specific trade to potentially triple your money in just three months. You won't find this information anywhere else!

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

GSK PHARMA SHARE PRICE


Nov 20, 2019 (Close)

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK PHARMA 8-QTR ANALYSIS

COMPARE GSK PHARMA WITH

MARKET STATS